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lavage (BAL) has a sensitivity of 43% to detect IPA (12 published studies
including 195 patients with histologically proven IPA). Current treatment of
IPA consists mainly of amphothericin B. Lung resection (LR) for IPA is
rarely considered because of fea .... of peri-operative bleeding and infection.
However. the current literature on LR for IPA (> 100 patients) shows an
acccptable complication ratc: blccding 7°,{,, air leak 4%, infection 3%,
surgery related mortality 1%, 3O-day mortality 9% and fungal relapse
10%. Analysis of 27 paticnts undergoing LR for IPA at our institution
rcvcaled: feasibility of LR irrespective of neutrophil- and platelet counts;
median duration ofoperation 120 min; median blood loss 300 ml; immediate
extubation in 96%; median ICU-stay I day; median duration of chest tube
drainage 2 days; secondary stemcell transplantation possible. Medium term
survival (12 months) was superior in patients undergoing LR compared to
patients with medical treatment alone.
Conclusion: lung resection should be considered in selected neutropenic
patients with invasive pulmonary aspergillosis.
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ITuS46 I Granulomatous diseases: Crohn's disease and
sarcoidosis
F. EI-Zaatari
Baylor College ofMedicine, HOIlSlon, Texas, Ullited States
Background: Crohn's disease (CD) and sarcoidosis (SA) are idiopathic
granulomatous diseases that share many features with mycobacterial infec-
tions. Reports on the association with cell wall deficient (CWO) forms of
Mycobacterium avium subsp. paratuberculosis (Map) are controversial.
Objectives: To confirm/refute the hypothesis of Map involvement in CD
and SA.
Methods and: Results: Our group and others used tissue and serum samples
from CD, SA and control patients to analyze by: 1) advanced cultural
techniques, 2) mycobacteria-specific polymerase chain reaction (PCR)
assays, 3) immunoblotting against recombinant clones expressing Map-
specific 35K (p35) and mycobacteria-specific 36K (p36)-antigens, 4) a
novel in situ hybridization (ISH) technique, bascd on the IS900 (a Map-
specific) probe, that was developed specifically for the detection of CWO
forms of Map, and 5) the recent use of macrolides and anti-mycobacterial
drags therapies.
Results: 1 and 2) CWO mycobacterial cells, specifically Map, were isolated
and/or identified from tissue specimens ofCD and SA and from breast milk
ofpatients with CD; 3) the majority ofCD patients sera (75% of53) reacted
with both p35 and p36 molecules versus only 2% of 58 controls. All 7 SA
patients reacted with p36; 4) CWO Map can be seen deep in fibroblasts, and
in acute and chronic inflammatory cells of active CD intestinal tissues with
granulomas; and 5) long term remission (possibly cure) in an increasing
number of CD patients.
Condusion: All the above evidence would suggest a causal role for myco-
bacteria in both diseases and treatment studies with anti-mycobacterial drags
including macrolides are warranted.
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IWeSSI Probiotics and streptococcal tonsillitis
K. Roos
ENT-dep., Lundby Hospital, Goteborg, Sweden
The significance of the normal fiora for the protection against infection in an
ecologic nisch has lately attracted an increased interest.
In the upper respiratory tract, alpha-streptococci have been in the focus of
interest in this regard. A lower number of alpha-streptococci have been
found in patients with recurrent streptococcal pharyngotonsillitis compared
to healthy controls, but also in otitis-prone children compared to non-otitis
prone and in children with secretory otitis media compared to healthy
children. Certain alpha-streptococci have been shown to have growth
inhibitory activity against common pathogenes in the upper respiratory
tract in vitro. We have shown that patients recolonized with alpha-
streptococci with interfering activity against beta-streptococci group A,
get less recurrences of streptococcal tonsillitis than placebo treated patients.
We have also isolated alpha-streptococcal strains with growth inhibitory
activity against pathogenes of acute otitis media. A significandy higher
number of otitis-prone children recolonized with these strains were healthy
during a randomized controlled study compared to placebo treated.
Conclusions: The results of ecological recolonization studies, both in
patients with streptococcal pharyngotonsillitis and in children with recur-
rent acute otitis media, indicate an important principle and stress the
importance of a normal balance between microorganisms in the upper
respiratory tract. This fact can be used in the protection against renewed
infections by recolonization with selected alpha-streptococcal strains in
paticnts with a disturbed normal fiora.
IWeS71 Probiotics in He/icobacter pylori infections
M. R. Gismondo, H. Mombelli
L. Sacco Teachitlg Hospital, University ofMilatl, ftaly
Interference of normal fiora with pathogenic micro-organisms growth and
vimlence has a long history of empirical observations and. more recently
scientific evidence. Probiotics, particnlarly lactic acid bacteria (Lactobacillus
and Bifidobacterium spp), are known to inhibit the growth of a wide range
of intestinal pathogcns in man and animals. Hdicobacter pylori is a peculiar
gastrointestinal pathogen, able to colonise stomach and cause.' peptic ulcer
and gastritis in man. In vitro studies demonstrated a strain-dependent and
concentration-dependent inhibitory activity ofLactobacilli against H. pylori.
Animal studies using gnotobiotic murine model proved both prevention of
H. pylori infection by Lactobacillus salivarius administration and suppression
of H. pylori by Lactobacillus salivarius administration after infection. The
suppression is supposed to be lactic acid mediated, and these results were also
reproduced with L. acidophilus and confirmed in human trials by oral
administration of sumatant, though H. pylori suppression was temporary.
Since the treatment of H. pylori infection is limited by deleterious side
effects, acquisition ofresistance, and sometimes lack oferadication, the use of
probiotics in prevention or treatment of this disease seems a very attractive
alternativc.
IWeSSI Treatment of diarrhoea with probiotics
S. L. Gorbach
Tujis University School of Medicine, Boston, MA, United States
Lactobacillus GG (LGG), a strain ofL. casei sps rhamnosus, has been studied
extensively with over 100 publications involving adults and children. In 15
placebo-controlled studies of acute diarrhea in children, LGG has been
shown to shorten the duration and reduce the severity ofthe acute episode. In
addition, duration of rotavirus shedding in the stools was reduced. These
studies were reported from various countries, including Finland, Italy,
Estonia, Russia, Thailand, Pakistan, and Peru. Similar findings were
reported recently in a study done in 287 children with acute diarrhea
enrolled in 13 pediatric centers within 10 European countries under the
auspices ofESPGHAN. LGG versus placebo was incorporated in ORS (oral
rehydration solution). The LGG group had significant reductions in dura-
tion of diarrhea and length of hospital stay. Fewer cases of protracted
diarrhea (> 6 days) were also seen in the LGG group. In another trial of
children given antibiotics for various respiratory infections, LGG treatment
was associatcd with less diarrhea side effects than placebo (17% with LGG vs
48% with placebo). The incidence of traveler's diarrhea was cut by 47% by
taking LGG as prophylaxis in a study ofAmcricans traveling to developing
countries. Other studies have shown benefit with LGG in treating cases of
antibiotic-associatcd diarrhea and relapsing Clostridium difficile colitis. LGG
is currendy ingested by millions of consumers each day in 25 countries as
dairy products or medicaments. Its excellent safety record has been docu-
mented by ongoing surveillance studies.
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IWeS10 I Surveillance systems responding quickly to
epidemics
O. L. Heymann
World Health Oganizatiotl, Geneva, Switzerland
With continuing globalization in travel and trade, global epidemic surveil-
lance is essential to ensure international public health security, The key
components of global epidemic surveillance are; epidemic intelligence;
epidemic preparedness; co-ordination of epidemic response. Epidemic
intelligence (accurate and timely information) about important disease
outbreaks should be delivered systematically and rapidly to key professionals
